dc.contributor.author | Prendergast, AJ | en_US |
dc.contributor.author | Penazzato, M | en_US |
dc.date.accessioned | 2019-12-04T16:09:20Z | |
dc.date.available | 2017-10-20 | en_US |
dc.date.issued | 2018-01 | en_US |
dc.identifier.issn | 2352-3018 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/61754 | |
dc.format.extent | E2 - E3 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | LANCET HIV | en_US |
dc.rights | CC-NC ND | |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.title | Timing of antiretroviral therapy in children with advanced HIV | en_US |
dc.type | Article | |
dc.rights.holder | 2017. Elsevier B.V. | |
dc.identifier.doi | 10.1016/S2352-3018(17)30193-5 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000418929700002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 1 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 5 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |